Thrombotic biomarkers for risk prediction of malignant disease recurrence in patients with early stage breast cancer

In cancer patients, hypercoagulability is a common finding. It has been associated with an increased risk of venous thromboembolism, but also to tumor proliferation and progression. In this prospective study of a large cohort of breast cancer patients, we aimed to evaluate whether pre-chemotherapy a...

Descrición completa

Detalles Bibliográficos

Principais autores:	Cinzia Giaccherini, Marina Marchetti, Giovanna Masci, Cristina Verzeroli, Laura Russo, Luigi Celio, Roberta Sarmiento, Sara Gamba, Carmen J. Tartari, Erika Diani, Alfonso Vignoli, Paolo Malighetti, Daniele Spinelli, Carlo Tondini, Sandro Barni, Francesco Giuliani, Fausto Petrelli, Andrea D’Alessio, Giampietro Gasparini, Filippo De Braud, Armando Santoro, Roberto Labianca, Anna Falanga, on behalf of the HYPERCAN Investigators
Formato:	Artigo
Idioma:	Inglês
Publicado:	Ferrata Storti Foundation 2020-06-01
Series:	Haematologica
Acceso en liña:	https://haematologica.org/article/view/9447
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!